Drug Eluting Stents Market - Size, Share, and
Forecast to 2026
Drug eluting stents are small expandable tubes made of wire that are inserted into the coronary
arteries of patients with atherosclerosis. Stent helps to hold the artery open to release a drug that
prevents blockage occurring in artery and improves the blood flow. This stent placement are
generally carried out in the procedure of coronary angioplasty. The drug eluting stents types are
bare metal coronary artery stents, coronary artery restenosis, coronary artery stents, coronary
revascularization, paclitaxel eluting coronary artery stents, sirolimus eluting coronary artery stents,
target vessel revascularization. The coronary artery stents are small cylindrical device used in
percutaneous coronary intervention (PCI) this device helps to relieve the symptoms of heart
diseases by improving the blood flow through the heart and also reduces the blockages. This type of
coronary artery stents are more beneficial for the patients who are suffering from coronary artery
diseases such as myocardial infarction. Drug eluting stents mostly consist of 3 parts the sent
platform, polymer coating which has 1 to 3 layers of polymers coated and the drug which is mainly
to inhibit neointimal growth.
Download PDF Brochure Of This Research Report @
https://www.coherentmarketinsights.com/insight/request-pdf/566
The drug eluting stents plays a major role in angioplasty to treat atherosclerosis, as the procedure is
minimally invasive, it is economically beneficial to the patient and helps patient to get cure rapidly.
Market Dynamics
Rise in incidence of cardiovascular disease, heart failure and coronary heart disease cases due to
increase in the prevalence of diabetes, obesity, high blood pressure worldwide is expected to favor
the demand for drug eluting stents around the globe.